Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Leo Pharma, a Danish dermatology drug specialist, has signed a research and licensing agreement with Germany’s 4SC Discovery to research, develop, and commercialize an oral treatment for inflammatory skin disease. The partners say they are working on a compound in early-stage development that could significantly reduce symptoms of psoriasis. 4SC will receive $1.3 million in R&D financing and could get up to $125 million in milestone payments plus additional royalties.
This article has been sent to the following recipient: